SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-23-001685
Filing Date
2023-02-10
Accepted
2023-02-09 17:48:22
Documents
71
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-10k_20221231.htm   iXBRL 10-K 3011772
2 EX-4.2 vktx-ex42_8.htm EX-4.2 60862
3 EX-23.1 vktx-ex231_11.htm EX-23.1 2806
4 EX-31.1 vktx-ex311_9.htm EX-31.1 20329
5 EX-31.2 vktx-ex312_7.htm EX-31.2 20308
6 EX-32.1 vktx-ex321_10.htm EX-32.1 12673
7 GRAPHIC gxfalnu50uob000001.jpg GRAPHIC 29659
  Complete submission text file 0001564590-23-001685.txt   10929072

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA vktx-20221231.xsd EX-101.SCH 64227
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20221231_cal.xml EX-101.CAL 61167
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20221231_def.xml EX-101.DEF 208934
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20221231_lab.xml EX-101.LAB 505504
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20221231_pre.xml EX-101.PRE 396064
65 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10k_20221231_htm.xml XML 2090724
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 23607614
SIC: 2834 Pharmaceutical Preparations